Vorinostat Not Yet Recruiting Phase 1 Trials for Metastatic Breast Cancer / Breast Cancer Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03742245Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer